Overview
Acute biliary tract infections encompass conditions like cholecystitis and cholangitis, often requiring prompt antimicrobial therapy to prevent complications such as sepsis and organ failure 1.Diagnosis
Clinical presentation includes right upper quadrant pain, fever, jaundice, and leukocytosis 1.
Imaging studies (US, CT, MRCP) to assess biliary anatomy and identify gallstones or obstruction 1.
Laboratory tests: Elevated liver enzymes (ALT, AST), bilirubin, and inflammatory markers (CRP, WBC) 1.
Culture and sensitivity from bile or blood samples to guide antibiotic therapy 1.Management
First-line treatment: Intravenous antibiotics; ofloxacin (400 mg IV every 12 hours) followed by oral administration is effective and safe compared to ceftriaxone 1.
Alternative regimen: Combination of penicillin with an aminoglycoside is traditionally recommended but should be avoided due to nephrotoxicity concerns 1.
Supportive care: Fluid resuscitation, pain management, and close monitoring for complications such as sepsis 1.
Surgical intervention: Considered for patients with refractory symptoms, complications (e.g., abscess, perforation), or failure to respond to medical therapy 1.Special Populations
Renal impairment: Ofloxacin may be preferred over aminoglycosides due to lower nephrotoxicity risk 1.
No specific data: Limited information provided regarding pediatrics, elderly, or pregnancy in the given abstracts 1.Key Recommendations
Use intravenous ofloxacin (400 mg every 12 hours) as an effective and safe monotherapy for acute biliary tract infections, transitioning to oral administration post-improvement 1 (Evidence: Strong).
Avoid aminoglycosides due to increased risk of renal toxicity in patients with acute biliary tract infections 1 (Evidence: Moderate).
Monitor closely for clinical response and consider surgical intervention for non-responsive cases or complications 1 (Evidence: Expert opinion).References
1 Karachalios GN, Nasiopoulou DD, Bourlinou PK, Reppa A. Treatment of acute biliary tract infections with ofloxacin: a randomized, controlled clinical trial. International journal of clinical pharmacology and therapeutics 1996. link